NCT03921554: A reported trial by Adeline Vanderver, MD
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03921554 |
|---|---|
| Title | Janus Kinase Inhibitor (Baricitinib) for Aicardi Goutières Syndrome |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 3, 2019 |
| Completion date | Jan. 4, 2024 |
| Required reporting date | Jan. 4, 2025, midnight |
| Actual reporting date | Dec. 9, 2024 |
| Date last checked at ClinicalTrials.gov | April 30, 2025 |
| Days late | None |